This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Columbia University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2025.
Company Filing History:
1 out of 2,551 
1 out of 3,690 
Years Active: 2025
Title: The Innovative Mind of Candice Gurbatri
Introduction
Candice Gurbatri is a pioneering inventor based in New York, NY (US). She has made significant contributions to the field of cancer treatment through her innovative work on programmable bacteria. Her research focuses on developing advanced therapeutic methods that target tumors effectively.
Latest Patents
Candice holds 1 patent for her groundbreaking invention titled "Programmable bacteria for the treatment of cancer." This patent discloses programmable bacteria designed for tumor-targeted immunotherapeutic delivery. The bacteria feature synchronized lysis circuits contained in a single operon, which can be engineered to produce anti-cancer therapeutic agents. These agents include nanobodies against immune checkpoint inhibitors, toxins, tumor antigens, cytokines, and chemokines. The patent also outlines methods for curing and treating cancer using these programmable bacteria.
Career Highlights
Throughout her career, Candice has worked with prestigious institutions, including Columbia University and the United States Department of Health and Human Services. Her work has been instrumental in advancing cancer treatment methodologies and has garnered attention in the scientific community.
Collaborations
Candice has collaborated with notable colleagues such as Nicholas Arpaia and Tal Danino. Their combined expertise has contributed to the development of innovative solutions in cancer therapy.
Conclusion
Candice Gurbatri's work exemplifies the spirit of innovation in the field of medical research. Her contributions to programmable bacteria for cancer treatment highlight her commitment to improving patient outcomes and advancing scientific knowledge.